logo
15:45 Feb 25

Procter & Gamble Health Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
5136.00
-25.00 (-0.48%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Procter & Gamble Health Ltd. Financials

Procter & Gamble Health Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
5136.00
-25.00 (-0.48%)
15:45 Feb 25
Quality
image/svg+xml

68/100
High Financial Strength

Valuation
image/svg+xml

34/100
Mid Valuation

Technical

37/100
Technically Neutral

Strength

6

Weakness

6

Opportunity

0

Threats

1

43.65 %

ROE %

29.51 %

ROA %

176.81

EPS

323.47

BVPS

0.00 %

Net Profit Margin

Jun 2021 Jun 2022 Jun 2023 Jun 2024 Mar 2025
Net Sales
1008.73 1114.41 1229.62 1151.26 934.17
Operating Expenses +
762.71 846.73 904.94 845.26 615.78
Raw Material
310.28 344.55 358.99 329.69 247.75
Increase Decrease in Cost
4.54 -4.75 2.85 0.87 14.75
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
150.47 167.56 206.17 215.16 142.06
Miscellaneous Expenses
339.74 381.03 416.45 378.46 305.54
Operating Profit
246.02 267.68 324.68 306 318.39
Other Income
18.1 13.19 18.39 15.63 10.35
Depreciation
30.04 27.08 28.1 27.4 16.69
Interest
0.8 0.42 0.77 0.72 0.43
Profit before tax and exceptio..
233.28 253.37 314.2 293.51 311.62
Exceptional Items
0 0 0 -20.19 0
PBT
233.28 253.37 314.2 273.32 311.62
Provision for Taxation
56.48 60.85 84.73 72.34 77.21
Net Profit
176.8 192.52 229.47 200.98 234.41
NET Profit after MI
0 0 0 0 0
EPS
107 116 138 133 141
Operating Profit Margin (%)
24.39 24.02 26.4 26.58 34.08
Net Profit Margin (%)
17.53 17.28 18.66 17.46 25.09

Procter & Gamble Health Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 51.80 51.80 51.80 51.80 51.80 51.80
FII 7.00 7.20 7.00 6.90 7.00 6.60
Public 13.80 13.90 14.10 14.20 14.70 14.80
Others 27.40 27.10 27.10 27.10 26.50 26.80
Shareholder Shares Holding %
Research 360 logo
Download Our App On: